Powell Gilbert hires life sciences patent litigator
IP law firm Powell Gilbert has expanded its life sciences team with the appointment of James Bergus.
EMA backs switch to biosimilars
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.
Swiss pharma company reveals SCOTUS appeal plans
Federal Circuit denies petition to rehear dispute over multiple sclerosis medicine | Company will petition highest court over invalidity ruling.
Pharma company hit with racial discrimination lawsuit
Pfizer’s ‘Breakthrough’ programme is aimed at Black, Latino and Native Americans | A healthcare membership organisation filed the complaint.
‘Pervasive abuse’ of patent system at root of drug pricing crisis: I-MAK
Report found that four times as many patents are granted on the top ten drugs in the US, compared to Europe | Non-profit says that the US’ patent system is ‘broken’.
Swiss watchdog investigates Novartis over patent use
Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition
MPP inks deal with French pharma firm to fight malaria in low-income countries
Malaria remains endemic in 91 countries representing half of the world’s population | Licence is key to allow rapid access to innovation for those who need it most.
McGuireWoods gains two life sciences patent litigators
Law firm McGuire Woods has hired IP litigators Michael Nutter and Merritt Westcott, for its Chicago and Houston offices, respectively.
US company secures genetically modified rice ban against Chinese rival
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.
EIP unveils life sciences hub in Scandinavia
Patent law firm EIP has opened a new regional hub in Stockholm, Sweden with a focus on the life sciences.
